Your browser doesn't support javascript.
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2.
Prévost, Jérémie; Richard, Jonathan; Gasser, Romain; Ding, Shilei; Fage, Clément; Anand, Sai Priya; Adam, Damien; Gupta Vergara, Natasha; Tauzin, Alexandra; Benlarbi, Mehdi; Gong, Shang Yu; Goyette, Guillaume; Privé, Anik; Moreira, Sandrine; Charest, Hugues; Roger, Michel; Mothes, Walther; Pazgier, Marzena; Brochiero, Emmanuelle; Boivin, Guy; Abrams, Cameron F; Schön, Arne; Finzi, Andrés.
  • Prévost J; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
  • Richard J; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
  • Gasser R; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
  • Ding S; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada.
  • Fage C; Centre de Recherche du CHU de Québec, Université Laval, Quebec City, Quebec, Canada.
  • Anand SP; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
  • Adam D; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Médicine, Université de Montréal, Montréal, Quebec, Canada.
  • Gupta Vergara N; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
  • Tauzin A; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
  • Benlarbi M; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada.
  • Gong SY; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
  • Goyette G; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada.
  • Privé A; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada.
  • Moreira S; Laboratoire de Santé Publique du Québec, Institut Nationale de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada.
  • Charest H; Laboratoire de Santé Publique du Québec, Institut Nationale de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada.
  • Roger M; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada; Laboratoire de Santé Publique du Québec, Institut Nationale de Santé Publique du Québec, Sainte-Anne-de-Bellevue,
  • Mothes W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Pazgier M; Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Brochiero E; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Médicine, Université de Montréal, Montréal, Quebec, Canada.
  • Boivin G; Centre de Recherche du CHU de Québec, Université Laval, Quebec City, Quebec, Canada.
  • Abrams CF; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
  • Schön A; Department of Biology, The Johns Hopkins University, Baltimore, Maryland, USA.
  • Finzi A; Centre de Recherche du CHUM, axe Immunopathologie, Montreal, Quebec, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada. Electronic address: andre
J Biol Chem ; 297(4): 101151, 2021 10.
Article in English | MEDLINE | ID: covidwho-1377741
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The seasonal nature of outbreaks of respiratory viral infections with increased transmission during low temperatures has been well established. Accordingly, temperature has been suggested to play a role on the viability and transmissibility of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. The receptor-binding domain (RBD) of the Spike glycoprotein is known to bind to its host receptor angiotensin-converting enzyme 2 (ACE2) to initiate viral fusion. Using biochemical, biophysical, and functional assays to dissect the effect of temperature on the receptor-Spike interaction, we observed a significant and stepwise increase in RBD-ACE2 affinity at low temperatures, resulting in slower dissociation kinetics. This translated into enhanced interaction of the full Spike glycoprotein with the ACE2 receptor and higher viral attachment at low temperatures. Interestingly, the RBD N501Y mutation, present in emerging variants of concern (VOCs) that are fueling the pandemic worldwide (including the B.1.1.7 (α) lineage), bypassed this requirement. This data suggests that the acquisition of N501Y reflects an adaptation to warmer climates, a hypothesis that remains to be tested.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 Type of study: Experimental Studies Topics: Variants Limits: Humans Language: English Journal: J Biol Chem Year: 2021 Document Type: Article Affiliation country: J.jbc.2021.101151

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 Type of study: Experimental Studies Topics: Variants Limits: Humans Language: English Journal: J Biol Chem Year: 2021 Document Type: Article Affiliation country: J.jbc.2021.101151